Discover 3,602 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,602
Active & Responsive
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
for
Elevated Blood Pressure, Hypertension
Location: Valley Village CA, West Hills CA, Dallas TX, Houston TX,
Sponsor: Zona Health, Inc
Sex: All
Age: 22+
Code: NCT06843577
Recruiting
Active & Responsive
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Beverly Hills CA, Torrance CA, Huntington Beach CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06972446
Phase 2, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Valley Village CA, Monterey Park CA, Beverly Hills CA,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Beverly Hills CA, Los Angeles CA, Inglewood CA,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Beverly Hills CA, Huntington Park CA, Canoga Park CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
for
Aging, Frailty, Exercise Tolerance,
Location: Beverly Hills CA
Sponsor: Scott Silveira
Sex: All
Age: 60 - 70+
Code: NCT07144527
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Beverly Hills CA, Van Nuys CA, Northridge CA,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
Lupus Landmark Study: A Prospective Registry and Biorepository
Location: Beverly Hills CA, Tucson AZ, Calgary, Dallas TX,
Sponsor: Lupus Research Alliance
Sex: All
Age: 18 - 70+
Code: NCT05934149
Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Beverly Hills CA, Phoenix AZ, Glendale AZ, Chandler AZ,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Beverly Hills CA, Fullerton CA, Irvine CA, Fontana CA,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT07570862
Phase 2, Recruiting
Active & Responsive
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
for
Neurotrophic Keratitis
Location: Pasadena CA, West Fargo ND, Alexandria MN,
Sponsor: Krystal Biotech, Inc.
Sex: All
Age: 18+
Code: NCT06999733
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
for
Alzheimer Disease
Location: Los Angeles CA, Anaheim CA, Chino CA, Phoenix AZ,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT06585787
Phase 3, Recruiting
Active & Responsive
Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)
for
oGVHD, Ocular Graft Versus Host Disease
Location: Beverly Hills CA, Boston MA
Sponsor: Regenerative Ocular Immunobiologics LLC
Sex: All
Age: 18+
Code: NCT07776210
Phase 3, Recruiting
Active & Responsive
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Cancer Stage IV
Location: Beverly Hills CA, Nashville TN, Sarasota FL
Sponsor: MBQ Pharma
Sex: All
Age: 21+
Code: NCT06075810
Phase 1, Recruiting
Active & Responsive
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
for
Geographic Atrophy
Location: Beverly Hills CA, San Francisco CA, Sacramento CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 50+
Code: NCT05626114
Phase 2, Recruiting
Active & Responsive
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
for
Advanced Solid Tumor
Location: Beverly Hills CA, Houston TX, Pittsburgh PA
Sponsor: Strand Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06249048
Phase 1, Phase 2, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: Los Angeles CA, Anaheim CA, Lancaster CA, Scottsdale AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Active & Responsive
Motiva Implants® Post-Approval Study
for
Breast Implant
Location: Beverly Hills CA, Westlake Village CA, Los Gatos CA,
Sponsor: Motiva USA LLC
Sex: Female
Age: 22+
Code: NCT06938399
Recruiting
Active & Responsive
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis (AD)
Location: Beverly Hills CA, Santa Monica CA, West Hills CA,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07298395
Phase 2, Recruiting
Active & Responsive
ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer
for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC),